Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$324,634,309
+$72,783,957 QoQ
Shares Held
3,338,142
+5.6% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,580,924,343 across 526 Biotechnology names. RVMD ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in RVMD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $324,634,309 | 3,338,142 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $251,850,352 | 3,161,963 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $146,901,387 | 3,145,640 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $110,144,329 | 2,993,866 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $146,475,758 | 4,142,414 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $178,730,343 | 4,086,199 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $164,485,583 | 3,627,025 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $129,456,808 | 3,335,656 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $98,388,230 | 3,052,691 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $85,431,525 | 2,978,784 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $57,373,221 | 2,072,732 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $52,121,305 | 1,948,460 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $37,560,107 | 1,734,077 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $34,464,109 | 1,446,856 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $27,185,045 | 1,378,552 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,720,623 | 1,165,758 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $28,595,204 | 1,120,941 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,775,019 | 1,103,497 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $29,736,631 | 1,080,939 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $29,964,400 | 944,058 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $35,722,168 | 778,600 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $25,431,230 | 642,365 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $21,788,280 | 626,100 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,055,401 | 255,160 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,648,436 | 120,878 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||